320 Participants Needed

Personalized Treatment for Eating Disorders

(T-NIPT-ED Trial)

EC
CA
JI
Overseen ByJaelin Isquith, B.A.
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Louisville
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to develop a personalized treatment for eating disorders (EDs) that considers each person's unique situation and social context. Researchers will compare a new personalized approach, Transdiagnostic Network Informed Personalized Treatment (T-NIPT-ED), with the current gold-standard treatment, Cognitive Behavioral Therapy Enhanced (CBT-E), to determine which is more effective. The trial seeks participants with an active eating disorder diagnosis, such as anorexia nervosa or other specified feeding or eating disorders, but not Avoidant/Restrictive Food Intake Disorder (ARFID). Participants should not have active suicidality, mania, or psychosis. As an unphased trial, this study offers participants the chance to contribute to pioneering research that could lead to more effective, personalized treatments for eating disorders.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

Is there any evidence suggesting that this trial's treatments are likely to be safe?

Research has shown that Enhanced Cognitive Behavioral Therapy for Eating Disorders (CBT-E) is generally safe. It has proven effective, particularly for bulimia nervosa and binge eating disorder. Most patients tolerate CBT-E well, with no major safety concerns reported in studies.

Early studies on Transdiagnostic Network Informed Personalized Treatment (T-NIPT-ED) suggest it is also safe. This new method uses personal data to tailor treatment and has shown promise in improving recovery rates. Initial trials have noted no significant safety issues.

Both treatments appear well-tolerated, with few side effects reported. Safety remains a top priority in research, and these treatments have shown promise in that area.12345

Why are researchers excited about this trial?

Researchers are excited about these treatments for eating disorders because they offer a personalized approach. Unlike standard therapies like Cognitive Behavioral Therapy (CBT) alone, the Transdiagnostic Network Informed Personalized Treatment tailors sessions based on real-time data from participants' daily experiences, making the treatment more individualized. This approach is expected to address the unique needs of each patient more effectively, potentially improving outcomes by focusing on the specific patterns and triggers that contribute to their eating disorder.

What evidence suggests that this trial's treatments could be effective for eating disorders?

This trial will compare Enhanced Cognitive Behavioral Therapy for Eating Disorders (CBT-E) with Transdiagnostic Network Informed Personalized Treatment. Research has shown that CBT-E effectively treats various eating disorders, particularly bulimia nervosa and binge eating disorder, leading to significant patient improvements. Despite its proven benefits, CBT-E remains underutilized.

In contrast, the Transdiagnostic Network Informed Personalized Treatment, which participants in this trial may receive, is a newer approach. Early results from pilot studies suggest it could be effective by focusing on each patient's individual needs and specific treatment methods, such as reducing feelings of shame. This personalized approach aims to provide more tailored treatment, potentially improving outcomes for people with eating disorders by considering the unique factors affecting each person.34567

Who Is on the Research Team?

CA

Cheri A Levinson, PhD

Principal Investigator

University of Louisville

Are You a Good Fit for This Trial?

This trial is for adults aged 18-65 with an active eating disorder, excluding ARFID. It's not suitable for individuals who are currently experiencing suicidal thoughts, mania, or psychosis.

Inclusion Criteria

I have an active eating disorder, but it's not ARFID.

Exclusion Criteria

Active Suicidality
Active Mania
Active psychosis

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Phase I: Ecological Momentary Assessment

Participants undergo two weeks of ecological momentary assessment to characterize individual mechanisms of treatment

2 weeks
Virtual assessments

Phase II: Treatment

Participants receive 10 sessions of either Enhanced Cognitive Behavioral Therapy for Eating Disorders (CBT-E) or personalized treatment based on ecological momentary assessment surveys

10 weeks
10 sessions (virtual)

Relapse Prevention

Participants complete one session of relapse prevention at the end of the treatment phase

1 week
1 session (virtual)

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Enhanced Cognitive Behavioral Therapy for Eating Disorders
  • Transdiagnostic Network Informed Personalized Treatment
Trial Overview The study compares a new personalized treatment (T-NIPT-ED) using mobile technology and individual modeling to the standard Cognitive Behavioral Therapy Enhanced (CBT-E) in treating eating disorders.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: Transdiagnostic Network Informed Personalized TreatmentExperimental Treatment1 Intervention
Group II: Cognitive Behavioral Therapy for Eating DisordersActive Control1 Intervention

Enhanced Cognitive Behavioral Therapy for Eating Disorders is already approved in United States, European Union for the following indications:

🇺🇸
Approved in United States as CBT-E for:
🇪🇺
Approved in European Union as CBT-E for:

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Louisville

Lead Sponsor

Trials
353
Recruited
76,400+

National Institute of Mental Health (NIMH)

Collaborator

Trials
3,007
Recruited
2,852,000+

Published Research Related to This Trial

In a study of 122 patients with eating disorders, it was found that changes in cognitions about body shape are crucial for symptom improvement, with overvaluation of shape being a key predictor of other symptoms.
The analysis revealed different symptom change processes based on childhood maltreatment history, suggesting that tailored therapeutic approaches may be necessary for individuals with such backgrounds to reduce dropout and relapse rates.
Breaking the cycle: Identifying key symptom pathways of eating disorders and the influence of childhood maltreatment.Kopland, MCG., Vrabel, K., Slof-Op 't Landt, M., et al.[2023]
Cognitive Behavioral Therapy (CBT) and Interpersonal Psychotherapy (IPT) both effectively influenced the relationships among symptoms of Binge-Eating Disorder (BED) in a study of 392 adults, indicating that both treatments can be beneficial.
The symptom of shape concern was identified as the most strongly interconnected and significantly predicted remission indicators, suggesting it could be a key target for future interventions in treating BED.
Examining changes in binge-eating disorder network centrality and structure in patients treated with cognitive-behavioral therapy versus interpersonal psychotherapy.Forrest, LN., Franko, DL., Thompson-Brenner, H., et al.[2023]
In a study of 56 participants with bulimia nervosa undergoing 16 sessions of cognitive behavior therapy (CBT), specific patterns of change in eating disorder symptoms were identified that can predict worsening symptoms after treatment.
Individuals who showed a rapid increase in binge eating frequency were more likely to experience a recurrence of compensatory behaviors, suggesting that monitoring these trajectories can help personalize treatment for better long-term outcomes.
Latent trajectories of symptom change during cognitive-behavior therapy predict post-treatment worsening of symptoms: a preliminary examination among outpatients with bulimia-spectrum eating disorders.Presseller, EK., Lampe, EW., Michael, ML., et al.[2022]

Citations

Effectiveness of enhanced cognitive behavior therapy for ...Although there is clear evidence of the effectiveness of CBT(‐E) for EDs, it is not being used as widely in clinical practice as guidelines ...
Enhanced cognitive behaviour therapy for adolescents with ...The available data indicate that CBT-E is effective for adolescents with various types of eating disorders, demonstrating significant ...
Effectiveness of enhanced cognitive behavioral therapy (CBT ...Initial research in the UK suggests that CBT-E is more effective for EDs, especially bulimia nervosa (BN) and EDNOS, than the earlier version of CBT.
Absolute and relative outcomes of cognitive behavior ...This study confirmed that cognitive behavior therapy is effective in the treatment of bulimia nervosa and binge eating disorder, with a large ...
Remotely Delivered Cognitive Behavioral Therapy for ...Systematic reviews have established the effectiveness of CBT-E for adults when delivered face to face. However, few studies have evaluated ...
Recent Advances in Cognitive-Behavioural Therapy for Eating ...While cognitive behavioural therapy for eating disorders (CBT-ED) has the most evidence to support its effectiveness, it requires substantial ...
Patient experiences of internet-based enhanced cognitive ...This study aimed to explore patients' experiences undergoing Internet-based guided self-help treatment based on Enhanced Cognitive Behavior Therapy (ICBT-E)
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security